Kinetics of liver repopulation after bone marrow transplantation.

[1]  E. Scott,et al.  Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion , 2002, Nature.

[2]  A. Ruifrok,et al.  Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. , 2002, The New England journal of medicine.

[3]  P. Rakic,et al.  Cell Proliferation Without Neurogenesis in Adult Primate Neocortex , 2001, Science.

[4]  A. Abbott.  The flu HQ , 2001, Nature.

[5]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Neil D. Theise,et al.  Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell , 2001, Cell.

[7]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[8]  Zu-hua Gao,et al.  Repopulation of liver endothelium by bone-marrow-derived cells , 2001, The Lancet.

[9]  G. Korbutt,et al.  Glucose-dependent insulin release from genetically engineered K cells. , 2000, Science.

[10]  S. Mckercher,et al.  Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. , 2000, Science.

[11]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[12]  A J Smith,et al.  Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. , 2000, Gastroenterology.

[13]  Xin Wang,et al.  Purified hematopoietic stem cells can differentiate into hepatocytes in vivo , 2000, Nature Medicine.

[14]  Rebekah Gardner,et al.  Liver from bone marrow in humans , 2000, Hepatology.

[15]  Sunil Badve,et al.  Derivation of hepatocytes from bone marrow cells in mice after radiation‐induced myeloablation , 2000, Hepatology.

[16]  R. Mulligan,et al.  Dystrophin expression in the mdx mouse restored by stem cell transplantation , 1999, Nature.

[17]  K. High,et al.  Gene therapy for the hemophilias. , 1999, Advances in veterinary medicine.

[18]  W. Mars,et al.  Bone marrow as a potential source of hepatic oval cells. , 1999, Science.

[19]  A. Kahn,et al.  Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes , 1998, Nature Medicine.

[20]  E. Laconi,et al.  Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. , 1998, The American journal of pathology.

[21]  S. Strom,et al.  Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. , 1998, The New England journal of medicine.

[22]  G Cossu,et al.  Muscle regeneration by bone marrow-derived myogenic progenitors. , 1998, Science.

[23]  A. Dalgleish,et al.  Repertoire breadth of human CD4+ T cells specific for HIV gp120 and p66 (primary antigens) or for PPD and tetanus toxoid (secondary antigens) , 1998, Human immunology.

[24]  D. Prockop,et al.  What holds us together? Why do some of us fall apart? What can we do about it? , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[25]  M. Grompe,et al.  Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. , 1997, The American journal of pathology.

[26]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[27]  R. Burk,et al.  Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. , 1996, Gastroenterology.

[28]  M. Grompe,et al.  Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[29]  S. Lindstedt,et al.  Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I , 1995, Nature Genetics.

[30]  O. Bagasra,et al.  Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Holzman,et al.  Repeated intraportal hepatocyte transplantation in analbuminemic rats. , 1995, Cell transplantation.

[32]  R. Palmiter,et al.  Replacement of diseased mouse liver by hepatic cell transplantation. , 1994, Science.

[33]  Philippe Soriano,et al.  Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. , 1993, Genes & development.

[34]  E. Yellin,et al.  Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. , 1993, Human gene therapy.

[35]  S. Lindstedt,et al.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase , 1992, The Lancet.

[36]  G. Kelsey,et al.  Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice. , 1992, Genes & development.

[37]  I. Weissman,et al.  Isolation of a candidate human hematopoietic stem-cell population. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Philippe Soriano,et al.  Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. , 1991, Genes & development.

[39]  F D Ledley,et al.  Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[40]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[41]  C. Caskey,et al.  Histochemical staining of clonal mammalian cell lines expressingE. coliβ galactosidase indicates heterogeneous expression of the bacterial gene , 1987, Somatic cell and molecular genetics.

[42]  M. Grompe,et al.  Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. , 2002, Molecular genetics and metabolism.

[43]  S. Strom,et al.  Hepatocyte transplantation for the treatment of human disease. , 1999, Seminars in liver disease.

[44]  M. Grompe,et al.  Erratum: Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I , 1996, Nature Genetics.

[45]  A. Horwich.  Inherited hepatic enzyme defects as candidates for liver-directed gene therapy. , 1991, Current topics in microbiology and immunology.

[46]  J. W. Campbell,et al.  Distribution of glutamine synthetase and carbamoyl-phosphate synthetase I in vertebrate liver. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Wang,et al.  Changing potency by spontaneous fusion , 2022 .